BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Chinese Patent Office

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,560,122

« Back to Dashboard

Which drugs does patent 7,560,122 protect, and when does it expire?

Patent 7,560,122 protects DICLEGIS and BONJESTA and is included in two NDAs. There has been one Paragraph IV challenge on Diclegis.

This patent has twelve patent family members in eleven countries.

Summary for Patent: 7,560,122

Title:Pharmaceutical dosage form bearing pregnancy-friendly indicia
Abstract: A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to improve patient compliance with medically recommended dosage regimen resulting in improved product effectiveness. The pregnancy-friendly indicia is also apt to diminish the incidence of erroneous dispensing of or erroneous ingestion of pharmaceutical dosage forms not intended for pregnant women. Also disclosed is a method for achieving improved patient compliance resulting in improved product effectiveness. Also disclosed is a method for diminishing the incidence of erroneous dispensing of or erroneous ingestion of dosage forms not intended for pregnant women. Said methods comprising providing a pharmaceutical dosage form, intended for use by pregnant women, bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.
Inventor(s): Gervais; Eric (Laval, CA), Atanackovic; Gordana (Dollard-des-Ormeaux, CA), Hebert; Raymond (Ile Bizard, CA)
Assignee: Duchesnay Inc. (Laval, Quebec, CA)
Application Number:10/611,803
Patent Claim Types:
see list of patent claims
Compound; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
DuchesnayDICLEGISdoxylamine succinate; pyridoxine hydrochlorideTABLET, DELAYED RELEASE;ORAL021876-001Apr 8, 2013ABRXYesYes► Subscribe► Subscribe► SubscribeY
DuchesnayBONJESTAdoxylamine succinate; pyridoxine hydrochlorideTABLET, EXTENDED RELEASE;ORAL209661-001Nov 7, 2016RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,560,122

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Canada2392486Jul 05, 2002

International Patent Family for Patent: 7,560,122

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan200400835► Subscribe
Netherlands1023797► Subscribe
Monaco200066► Subscribe
ItalyUD20030145► Subscribe
Ireland20030484► Subscribe
Greece1004641► Subscribe
Greece20030100286► Subscribe
France2841783► Subscribe
Canada2392486► Subscribe
Belgium1016043► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Cantor Fitzgerald
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: